Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPINE: Aripiprazole Lauroxil vs Paliperidone Palmitate in Schizophrenia
NCT03345979Phase 3Completed
- Sponsor
- Alkermes
- Start
- Nov 2017
- Primary completion
- Mar 2019
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole lauroxil in schizophrenia, sponsored by Alkermes. Started Nov 2017; status: completed.
02
Drugs
aripiprazole lauroxil
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03345979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345979.